Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BULK DEALS
Bulk Deals      
Genomic Valley Biotech Ltd.
BSE Code 539206
ISIN Demat INE574D01010
Book Value 12.76
NSE Code NA
Dividend Yield % 0.00
Market Cap 143.56
P/E 40.44
EPS 1.16
Face Value 10  
 
 
   
Deal DateCompany NameClient NameTranQty.(000's)ValuePriceTrade(Rs.in Lakhs)Close Price
25-Oct-2024 Genomic Valley YOGESH AGRAWALSELL 4803298.464729230.7247
23-Oct-2024 Genomic Valley SATISH KUMAR SHARMASELL 2197896.862128789.0847
22-Oct-2024 Genomic Valley PURUSHOTHAMAN SHAJIBUY 1858098.45182920147
22-Oct-2024 Genomic Valley YOGESH AGRAWALSELL 2000099.1198200047
21-Oct-2024 Genomic Valley SATISH KUMAR SHARMASELL 2232299.412219030.0247
18-Oct-2024 Genomic Valley PARUL AGRAWALSELL 1975694.25186200347
18-Oct-2024 Genomic Valley SATISH KUMAR SHARMASELL 2540094.25239395047
18-Oct-2024 Genomic Valley VIKRAMASHOKKUMARJAINBUY 7900094.25744575047
16-Oct-2024 Genomic Valley PARUL AGRAWALSELL 5030092.61465828347
16-Oct-2024 Genomic Valley VIKRAMASHOKKUMARJAINBUY 8100092.43748683047
14-Oct-2024 Genomic Valley PARUL AGRAWALSELL 3400090.25306850047
11-Oct-2024 Genomic Valley PURUSHOTHAMAN SHAJIBUY 2024387.791777132.9747
12-Sep-2024 Genomic Valley YOGESH AGRAWALSELL 1534173.281124188.4847
03-Sep-2024 Genomic Valley YOGESH AGRAWALSELL 1684568.6115556747
02-Sep-2024 Genomic Valley PARUL AGRAWALSELL 1659667.451119400.247
30-Aug-2024 Genomic Valley PARUL AGRAWALSELL 1594766.21055691.447
31-Jul-2024 Genomic Valley SATISH KUMAR SHARMASELL 2133354.041152835.3247
30-Jul-2024 Genomic Valley SATISH KUMAR SHARMASELL 2788353.041478914.3247
21-Dec-2023 Genomic Valley JAYSUKHLAL TRIBHOVANDAS DOSHISELL 2000028.1256240047
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.